Literature DB >> 2108983

Antiphospholipid antibodies in unselected patients with repeated abortion.

J Balasch1, J Font, A López-Soto, R Cervera, I Jové, F J Casals, J A Vanrell.   

Abstract

We have studied, prospectively, the incidence of several antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-phosphatidylserine, anti-phosphatidic acid, anti-phosphatidylinositol and anti-thromboplastin antibodies) in 65 consecutive patients with two or more (range 2-8, mean 3.1) abortions. Lupus anticoagulant activity was detected in seven (10.7%) patients and all of them exhibited other antiphospholipid antibodies. Of the previous pregnancies in these seven women, 88% had ended in spontaneous abortion. Four of them achieved pregnancy after low-dose aspirin therapy was started, and carried successfully to term. It is concluded that antiphospholipid antibodies, namely lupus anticoagulant, should be routinely screened in the recurrent spontaneous aborter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108983     DOI: 10.1093/oxfordjournals.humrep.a137038

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

Review 1.  Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease.

Authors:  M Ángeles Martínez-Zamora; Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  Antiphospholipid antibodies: which and when?

Authors:  R Cervera; J Font; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

Review 3.  Management of the antiphospholipid syndrome.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Auto Immun Highlights       Date:  2010-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.